Standardized symptom measurement of individuals with early lyme disease over time

Kathleen T. Bechtold, Alison W. Rebman, Lauren A. Crowder, Douglas E Johnson-Greene, John N. Aucott

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objective: Understanding the Lyme disease (LD) literature is challenging given the lack of consistent methodology and standardized measurement of symptoms and the impact on functioning. This prospective study incorporates well-validated measures to capture the symptom picture of individuals with early LD from time of diagnosis through 6-months post-treatment. Method: One hundred seven patients with confirmed early LD and 26 healthy controls were evaluated using standardized instruments for pain, fatigue, depressive symptoms, functional impact, and cognitive functioning. Results: Prior to antibiotic treatment, patients experience notable symptoms of fatigue and pain statistically higher than controls. After treatment, there are no group differences, suggesting that symptoms resolve and that there are no residual cognitive impairments at the level of group analysis. However, using subgroup analyses, some individuals experience persistent symptoms that lead to functional decline and these individuals can be identified immediately post-completion of standard antibiotic treatment using well-validated symptom measures. Conclusions: Overall, the findings suggest that ideally-treated early LD patients recover well and experience symptom resolution over time, though a small subgroup continue to suffer with symptoms that lead to functional decline. The authors discuss use of standardized instruments for identification of individuals who warrant further clinical follow-up.

Original languageEnglish (US)
Pages (from-to)129-141
Number of pages13
JournalArchives of Clinical Neuropsychology
Volume32
Issue number2
DOIs
StatePublished - 2017

Fingerprint

Lyme Disease
Fatigue
Anti-Bacterial Agents
Pain
Therapeutics
Prospective Studies
Depression

Keywords

  • Cognitive impairment
  • Fatigue
  • Lyme disease
  • Post-treatment Lyme disease syndrome
  • Symptom measurement

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology
  • Clinical Psychology
  • Psychiatry and Mental health

Cite this

Standardized symptom measurement of individuals with early lyme disease over time. / Bechtold, Kathleen T.; Rebman, Alison W.; Crowder, Lauren A.; Johnson-Greene, Douglas E; Aucott, John N.

In: Archives of Clinical Neuropsychology, Vol. 32, No. 2, 2017, p. 129-141.

Research output: Contribution to journalArticle

Bechtold, Kathleen T. ; Rebman, Alison W. ; Crowder, Lauren A. ; Johnson-Greene, Douglas E ; Aucott, John N. / Standardized symptom measurement of individuals with early lyme disease over time. In: Archives of Clinical Neuropsychology. 2017 ; Vol. 32, No. 2. pp. 129-141.
@article{4ed4306ccfe34fe8a80fcea1da10d2c4,
title = "Standardized symptom measurement of individuals with early lyme disease over time",
abstract = "Objective: Understanding the Lyme disease (LD) literature is challenging given the lack of consistent methodology and standardized measurement of symptoms and the impact on functioning. This prospective study incorporates well-validated measures to capture the symptom picture of individuals with early LD from time of diagnosis through 6-months post-treatment. Method: One hundred seven patients with confirmed early LD and 26 healthy controls were evaluated using standardized instruments for pain, fatigue, depressive symptoms, functional impact, and cognitive functioning. Results: Prior to antibiotic treatment, patients experience notable symptoms of fatigue and pain statistically higher than controls. After treatment, there are no group differences, suggesting that symptoms resolve and that there are no residual cognitive impairments at the level of group analysis. However, using subgroup analyses, some individuals experience persistent symptoms that lead to functional decline and these individuals can be identified immediately post-completion of standard antibiotic treatment using well-validated symptom measures. Conclusions: Overall, the findings suggest that ideally-treated early LD patients recover well and experience symptom resolution over time, though a small subgroup continue to suffer with symptoms that lead to functional decline. The authors discuss use of standardized instruments for identification of individuals who warrant further clinical follow-up.",
keywords = "Cognitive impairment, Fatigue, Lyme disease, Post-treatment Lyme disease syndrome, Symptom measurement",
author = "Bechtold, {Kathleen T.} and Rebman, {Alison W.} and Crowder, {Lauren A.} and Johnson-Greene, {Douglas E} and Aucott, {John N.}",
year = "2017",
doi = "10.1093/arclin/acw098",
language = "English (US)",
volume = "32",
pages = "129--141",
journal = "Archives of Clinical Neuropsychology",
issn = "0887-6177",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Standardized symptom measurement of individuals with early lyme disease over time

AU - Bechtold, Kathleen T.

AU - Rebman, Alison W.

AU - Crowder, Lauren A.

AU - Johnson-Greene, Douglas E

AU - Aucott, John N.

PY - 2017

Y1 - 2017

N2 - Objective: Understanding the Lyme disease (LD) literature is challenging given the lack of consistent methodology and standardized measurement of symptoms and the impact on functioning. This prospective study incorporates well-validated measures to capture the symptom picture of individuals with early LD from time of diagnosis through 6-months post-treatment. Method: One hundred seven patients with confirmed early LD and 26 healthy controls were evaluated using standardized instruments for pain, fatigue, depressive symptoms, functional impact, and cognitive functioning. Results: Prior to antibiotic treatment, patients experience notable symptoms of fatigue and pain statistically higher than controls. After treatment, there are no group differences, suggesting that symptoms resolve and that there are no residual cognitive impairments at the level of group analysis. However, using subgroup analyses, some individuals experience persistent symptoms that lead to functional decline and these individuals can be identified immediately post-completion of standard antibiotic treatment using well-validated symptom measures. Conclusions: Overall, the findings suggest that ideally-treated early LD patients recover well and experience symptom resolution over time, though a small subgroup continue to suffer with symptoms that lead to functional decline. The authors discuss use of standardized instruments for identification of individuals who warrant further clinical follow-up.

AB - Objective: Understanding the Lyme disease (LD) literature is challenging given the lack of consistent methodology and standardized measurement of symptoms and the impact on functioning. This prospective study incorporates well-validated measures to capture the symptom picture of individuals with early LD from time of diagnosis through 6-months post-treatment. Method: One hundred seven patients with confirmed early LD and 26 healthy controls were evaluated using standardized instruments for pain, fatigue, depressive symptoms, functional impact, and cognitive functioning. Results: Prior to antibiotic treatment, patients experience notable symptoms of fatigue and pain statistically higher than controls. After treatment, there are no group differences, suggesting that symptoms resolve and that there are no residual cognitive impairments at the level of group analysis. However, using subgroup analyses, some individuals experience persistent symptoms that lead to functional decline and these individuals can be identified immediately post-completion of standard antibiotic treatment using well-validated symptom measures. Conclusions: Overall, the findings suggest that ideally-treated early LD patients recover well and experience symptom resolution over time, though a small subgroup continue to suffer with symptoms that lead to functional decline. The authors discuss use of standardized instruments for identification of individuals who warrant further clinical follow-up.

KW - Cognitive impairment

KW - Fatigue

KW - Lyme disease

KW - Post-treatment Lyme disease syndrome

KW - Symptom measurement

UR - http://www.scopus.com/inward/record.url?scp=85017488855&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017488855&partnerID=8YFLogxK

U2 - 10.1093/arclin/acw098

DO - 10.1093/arclin/acw098

M3 - Article

C2 - 28365751

AN - SCOPUS:85017488855

VL - 32

SP - 129

EP - 141

JO - Archives of Clinical Neuropsychology

JF - Archives of Clinical Neuropsychology

SN - 0887-6177

IS - 2

ER -